Egol, Ailyn .
HRN: 25-70-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2025
CEFUROXIME 1.5GM (VIAL)
11/06/2025
11/13/2025
IV
1.5
Q8
Primary Ltcs With Btl
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes